Quick Takeaways
- Shay Capital LLC filed SCHEDULE 13G for Repare Therapeutics Inc. Common shares, no par value (RPTX).
- Disclosed ownership: 6.7%.
- Date of event: 20 Jan 2026.
Shay Capital LLC - 20 Jan 2026 SCHEDULE 13G Report for Repare Therapeutics Inc. Common shares, no par value (RPTX)
- Filing Manager
- Shay Capital LLC
- Reporting Manager
- Shay Capital LLC
- Symbol
- RPTX
- Shares outstanding
- 42,837,925 shares
- Disclosed Ownership
- 2,870,141 shares
- Ownership
- 6.7%
- Form type
- SCHEDULE 13G
- Filing time
- 27 Jan 2026, 16:00:24 UTC
- Date of event
- 20 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Shay Capital LLC disclosed 6.7% ownership in Repare Therapeutics Inc. Common shares, no par value (RPTX) on 20 Jan 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 27 Jan 2026, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Shay Capital LLC | 6.7% | 2,870,141 | 2,870,141 | 0 | Elan Foxman | Chief Financial Officer | |
| Shay Capital Holdings LLC | 6.7% | 2,870,141 | 2,870,141 | 0 | Elan Foxman | Chief Financial Officer |